Search
for

    Sort by

    Research 361–390 of 1000+

    1. Saw palmetto and finasteride in the treatment of category-iii prostatitis/chronic pelvic pain syndrome Current Urology Reports · 2005 · 5 citations
    2. Phytotherapy in Benign Prostatic Hyperplasia Elsevier eBooks · 2018 · 3 citations
    3. Effect of a Benign Prostatic Hyperplasia (BPH) Xenobiotic - Croton membranaceus Müll.Arg. Root Extract on CYP1A2, CYP3A4, CYP2D6, and GSTM1 Drug Metabolizing Enzymes in Rat Model 2020 · 1 citations
    4. Asociación entre disfunción eréctil y funcionalidad del subsistema conyugal en pacientes con hiperplasia prostática benigna REMUS - Revista Estudiantil de Medicina de la Universidad de Sonora · 2020 · 1 citations
    5. Benign Prostatic Hyperplasia Pharmacotherapy and Incident Ocular Surface Disease: Comparative Risk of Alpha-Blockers vs 5-Alpha Reductase Inhibitors Urology · 2026
    6. Re: The risk of psychiatric disorders in finasteride users with benign prostatic hyperplasia (BPH) and androgenetic alopecia (AGA): A population‐based case–control study Australasian Journal of Dermatology · 2024
    7. The risk of psychiatric disorders in finasteride users with benign prostatic hyperplasia and androgenetic alopecia: A population‐based case–control study Australasian Journal of Dermatology · 2024
    8. The Association of Male Pattern Baldness in Men with Benign Prostatic Hyperplasia Jordan Medical Journal · 2023
    9. Tratamientos fitoterapeúticos para la hipertrofia benigna de próstata: serenoa repens Metas de Enfermería · 2005
    10. La combinación de finasteride y doxazosina fue más efectiva que la monoterapia en la hiperplasia prostática benigna Evidencia actualizacion en la práctica ambulatoria · 2004
    11. The prognostic value of androgenetic alopecia and benign prostatic hyperplasia in men with COVID-19: a prospective multidisciplinaryobservational study of 766 patients from Turkey Journal of health sciences and medicine · 2022
    12. 2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review European Urology · 2023 · 710 citations
    13. Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors Cancer research · 2011 · 402 citations
    14. Risk factors for prostate cancer: a case-control study in Greece International Journal of Cancer · 1999 · 127 citations
    15. Endocrine control of benign prostatic hyperplasia Andrology · 2016 · 97 citations
    16. Wedelolactone, a medicinal plant-derived coumestan, induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt International Journal of Oncology · 2012 · 83 citations
    17. Doxil (Caelyx): an exploratory study with pharmacokinetics in patients with hormone-refractory prostate cancer Anti-cancer drugs · 2000 · 81 citations
    18. Novel Anti-Prostate Cancer Curcumin Analogues That Enhance Androgen Receptor Degradation Activity Anti-Cancer Agents in Medicinal Chemistry · 2009 · 73 citations
    19. Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation PLoS ONE · 2013 · 63 citations
    20. Treatment of chronic prostatitis/chronic pelvic pain syndrome International Journal of Antimicrobial Agents · 2008 · 50 citations
    21. Redefining hormone resistance in prostate cancer Therapeutic Advances in Medical Oncology · 2009 · 38 citations
    22. Effects of androgen deprivation on chronic bacterial prostatitis in a rat model International Journal of Urology · 2003 · 38 citations
    23. Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects The Journal of Sexual Medicine · 2012 · 35 citations
    24. HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond Endocrinology · 2019 · 30 citations
    25. Epidemiological study of prostate cancer (EPICAP): a population-based case–control study in France BMC Cancer · 2014 · 27 citations
    26. Medikamentöse Therapie des benignen Prostatasyndroms mit α1-Rezeptorblockern Grundlagen und klinische Ergebnisse Der Urologe · 2002 · 22 citations
    27. Androgenetic alopecia and prostate cancer: findings from an Australian case-control study. PubMed · 2002 · 21 citations
    28. Medikamentöse Therapie des benignen Prostatasyndroms Der Urologe · 2015 · 20 citations
    29. Hormonal manipulation of benign prostatic hyperplasia Current opinion in urology · 2012 · 18 citations
    30. Recent discoveries and developments of androgen receptor based therapy for prostate cancer MedChemComm · 2015 · 17 citations